Genecast
PrivateLast Round
Series E
Oct 27, 2020
Est. Valuation
$779.3M
Total Funding Raised
$417.19M
Company Overview
Genecast is a biotechnology company that develops solutions for non-invasive diagnosis and monitoring of cancer.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genecast Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Genecast Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Oct 27, 2020 | ||||
| Corporate Funding | Jan 6, 2020 | ||||
| Series D | Oct 30, 2019 | ||||
| Series C | Feb 11, 2018 | ||||
| Corporate Funding | Nov 23, 2017 | ||||
Series B | Feb 10, 2017 |
Genecast Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| China Chengtong Fund Management Co., Ltd. | Series E |
| Loyal Valley Capital | Series C |
| Shenzhen Sangel Venture Capital | Angel |
| Hillhouse Investment | Series E |
| Co-Win Ventures | Series D |
| Huasheng Capital | Series E |
| China International Capital Corporation | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2025
Developing real-time adaptive care for cancer patients with Invitrocue.
- Jun 17, 2025
Partnered with Invitrocue for personalized cancer care.
Genecast Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Genecast's valuation, stock price, and market status.